Cerebral vasospasm determines the prognosis of subarachnoid hemorrhage (SAH). The increased vascular reactiveness has an important role in the development of cerebral vasospasm. This study analyzed the roles of the receptor-mediated signaling and the myofilament Ca 2 + sensitivity in the increased vascular reactiveness in SAH, using the basilar artery of a rabbit SAH model. Endothelin-1, thrombin, and phenylephrine induced transient increases in [Ca 2 + ] i , myosin light chain phosphorylation, and contraction in the controls. All these responses were not only enhanced but also became sustained in SAH. In the sequential stimulation of thrombin receptor or a 1 -adrenoceptor, the second response was substantially attenuated in the controls, whereas it was maintained in SAH. The thrombin-induced contraction in SAH irreversibly persisted even after terminating the thrombin stimulation. This contraction was completely reversed by trypsin and a Ga q inhibitor YM254890, thus suggesting the sustained receptor activity during the sustained contraction. YM254890 also inhibited the endothelin-1and phenylephrine-induced sustained contraction. Furthermore, the GTPcS-induced transient contraction in the control a-toxin-permeabilized strips was converted to a sustained contraction in SAH. The results provide the first evidence that the feedback inactivation of the receptor activity and the myofilament Ca 2 + sensitivity was impaired in SAH, thus contributing to the increased vascular reactiveness.
Introduction
Cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH) is characterized by the delayed and prolonged contraction of cerebral arteries, which may cause cerebral ischemia, thereby leading to death or neurological deficit in SAH patients . Therefore, the prevention and treatment of vasospasm have an important role in the manage-ment of SAH patients. The increased vascular reactiveness has a key role in the pathogenesis of the delayed onset of cerebral vasospasm after SAH (Kai et al, 2008) . The contractile reactiveness of the cerebral arteries to various putative spasmogens, including endothelin-1 (Ide et al, 1989; Vatter et al, 2007) , thrombin Maeda et al, 2007) , platelet-derived growth factor (Maeda et al, 2009) , and 5-HT (Hansen-Schwartz et al, 2003) , have been shown to increase in SAH. Consistent with these increased contractile responses, the expression of ET A receptor, proteinase-activated receptor 1 (PAR 1 ), and 5-HT 1B is upregulated in SAH (Hansen-Schwartz et al, 2003; Ide et al, 1989; Kai et al, 2007; Maeda et al, 2007; Vatter et al, 2007) . The receptor upregulation therefore has a very important role in the increased vascular reactiveness in SAH. However, this can explain the increased responses of only certain spasmogens that exert an effect on the upregulated receptors. Conversely, the changes in the expression of intracellular signaling proteins, such as RhoA and protein kinase C, have also been shown in SAH, and this could explain the mechanism for the increased responses to various spasmogens (Laher and Zhang, 2001; Miyagi et al, 2000; Sato et al, 2000) . However, the changes in the regulatory mechanisms of smooth muscle contraction remain controversial (Maeda et al, 2003; Miyagi et al, 2000; Sato et al, 2000) . Therefore, the mechanism underlying the increased vascular reactiveness in SAH still needs to be elucidated.
In many cases, the contractile responses to agonists show diminished responsiveness during the persisted or repeated stimulations. These phenomena are referred to as desensitization or tachyphylaxis, respectively, which represent an important physiological 'feedback' mechanism that protects against both acute and chronic receptor overstimulation (Ferguson, 2001; Lurie et al, 1985; Miasiro and Paiva, 1990; Trejo, 2003) . This feedback regulation could be attributable to not only the inactivation of receptors, but also downregulation of signaling function at the post-receptor level (Ferguson, 2001; Gong et al, 1997) . Importantly, the mechanism of receptor desensitization is impaired under various pathological conditions, such as hypoxia, cancer, and diabetes (Booden et al, 2004; Endo et al, 2005; Hinton et al, 2007) . The impairment of feedback regulation could thus have an important role in cerebral vasospasm in SAH. White and Robertson (1987) proposed that the desensitization and tachyphylaxis of vascular reactiveness might help to prevent the development of cerebral vasospasm after SAH. However, whether and how such feedback regulation of the vascular reactiveness is altered in SAH still remains to be investigated.
The present study used a rabbit SAH model to examine the changes in the contractile responses of the isolated basilar artery to endothelin-1, thrombin, and phenylephrine, as representatives of putative spasmogens. The analysis was focused on the changes in the smooth muscle reactiveness; therefore, it was conducted in the absence of endothelium. This study evaluated not only the extent of the contractile responses, but also the temporal correlation among cytosolic Ca 2 + concentrations ([Ca 2 + ] i ), myosin light chain (MLC) phosphorylation, and tension development during the prolonged stimulation as well as the tachyphylaxis of contractile responses. The level of expression of receptors was also evaluated with an immunoblot analysis. Furthermore, any changes in the myofilament Ca 2 + sensitivity were evaluated using a-toxin-permeabilized preparations. The result shows, for the first time, that the impairment of negative feedback regulation of receptor signaling and myofilament Ca 2 + sensitivity has an important role in the increased vascular reactiveness after SAH.
Materials and methods

Preparation of the Rabbit Subarachnoid Hemorrhage Model
This study protocol was approved by the Animal Care and Use Committee, Kyushu University. Adult male Japanese white rabbits (2.5 to 3.0 kg) were anesthetized with an intramuscular injection of ketamine (40 mg/kg weight) and an intravenous injection of sodium pentobarbital (20 mg/kg weight). On day 0, 0.5 mL of cerebrospinal fluid was aspirated percutaneously from the cisterna magna with use of a 23-gauge butterfly needle, and then 2.5 mL of autologous arterial blood obtained from the middle branch of the ear artery was injected. The animal was then kept in a prone position with the head tilting down at 301 for 30 mins. On day 2, a second injection of autologous blood was similarly performed. The control animals received injections of the same volume of normal physiological salt solution (PSS) instead of the autologous blood.
Preparation of Intact Ring of Basilar Artery
On day 7, the rabbits were heparinized (1,000 U) and then killed by intravenous injection of an overdose of sodium pentobarbital (120 mg/kg weight) and exsanguinated from the common carotid artery. Exposing the brain revealed that the clot formation was observed over the surface of the pons and the basilar artery in SAH. Immediately after the whole brain was excised en bloc and the clot was removed, the narrowing of the basilar artery in SAH was observed under a binocular microscope. The external diameter of the basilar artery was 0.58±0.01 mm in the controls (n = 5) and 0.35 ± 0.03 mm in SAH (n = 5). The basilar artery of SAH was thus significantly (P < 0.001) narrowed to 60.5% ± 5.1% of the controls.
The basilar artery was then immediately excided and cut into ring preparations measuring 500 mm wide. To remove the endothelium, the internal surface of arteries was rubbed with hair. The removal of endothelium was confirmed by the loss of the relaxant response to acetylcholine. The ring preparations were kept in normal PSS at room temperature until use. These preparations were referred to as 'intact' preparations, regardless of the presence or absence of endothelium, in contrast to the 'permeabilized' preparations, which will be described below.
Simultaneous Measurement of Changes in the Cytosolic Ca 2 + Concentrations and Developed Tension in Intact Ring Preparations of the Basilar Artery
The arterial rings were loaded with the Ca 2 + indicator dye, fura-2, by incubation in Dulbecco's modified Eagle's medium containing 25 mmol/L fura-2 acetoxymethyl ester and 5% (v/v) fetal bovine serum for 90 mins at 371C. The fura-2-loaded rings were washed with normal PSS to remove the dye in the extracellular space, and were then mounted horizontally between two tungsten wires in an organ bath containing 2 mL buffer. One of the wires was connected to the force transducer U gauge (Minebea, Nagano, Japan), whereas the other was fixed. The preparations were equilibrated in normal PSS at 371C for at least 60 mins before starting the experimental protocol. During the 60-min equilibration period, the rings were stimulated with 118 mmol/L K + every 15 mins, and the resting load was increased in a stepwise manner. The resting load was finally adjusted to 50 mg, which was the minimal load to give the maximal tension development in response to 118 mmol/L K + . The measurement was then performed at 371C in PSS aerated with 95% O 2 and 5% CO 2 . The changes in the fura-2 fluorescence intensities obtained with 340 nm (F340) and 380 nm (F380) excitation and their ratio (F340/F380) were monitored using a CAM-230 fluorometer (JASCO, Tokyo, Japan). The data were expressed as a percentage, assigning the values of fluorescence ratio and tension obtained in normal PSS and 118 mmol/L K + PSS as 0% and 100%, respectively, unless otherwise specified. Loading of fura-2 was confirmed to have no effect on the contractility of ring preparations, because the degree of tension obtained with 118 mmol/L K + in the fura-2-loaded rings (333.7±30.4 mg; n = 6) did not differ significantly from that obtained without fura-2 loading (316.2 ± 55.9 mg; n = 5). As specified in the figure legends, tension development was therefore measured without fura-2 loading in some cases. The pH value of the tissues bathed in PSS, in both the presence and absence of agonists, and the contractile response to high K + depolarization remained unchanged after a 2-h observation period (data not shown), thus suggesting that there was no significant loss in the integrity of the arterial rings.
Tension Measurement in the a -Toxin-Permeabilized Preparations of Basilar Artery
The arterial rings were permeabilized with 5,000 units/mL staphylococcal a-toxin in cytosolic substitution solution (CSS) for 30 mins at 251C, as previously described . The rings were then treated with 10 mmol/L A23187, a Ca 2 + ionophore, in Ca 2 + -free CSS for 15 mins to deplete the intracellular Ca 2 + stores. These permeabilized preparations were then mounted between two tungsten wires, as described above, and then were stretched to 1.5fold their resting length. After obtaining complete relaxation in Ca 2 + -free CSS, the experimental protocols was started and the tension development was recorded at 251C.
Analysis of the Myosin Light Chain (MLC) Phosphorylation with Phos-Tag Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
The phosphorylation of MLC was analyzed using a new method based on a Phos-tag technology (Takeya et al, 2008) . Phos-tag is a compound that specifically binds to a phosphate group. Therefore, SDS-PAGE containing polyacrylamide-bound Mn 2 + Phos-tag (Phos-tag SDS-PAGE) causes a mobility shift in protein, depending on the degree of phosphorylation (Takeya et al, 2008) . The samples for analysis were obtained during the measurement of tension in the intact preparations. In brief, at the indicated time points, the bathing buffer was promptly changed to 90% (v/v) acetone, 10% (w/v) trichloroacetic acid, and 10 mmol/L dithiothreitol (DTT) prechilled at À801C to stop the reaction. The specimens were then transferred to microcentrifuge tubes, and were then extensively washed and stored in acetone containing 10 mmol/L DTT. After the specimens were air-dried to remove acetone, the cellular protein was extracted in the sample buffer (50 mmol/L Tris-hydroxymethyl aminomethane, 2% (w/v) SDS, 5% (v/v) glycerol, 0.01% (w/v) NaN 3 , 0.01% (w/v) bromophenol blue, 5% (v/v) b-mercaptoethanol, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mmol/ml 4-aminidophenylmethane sulphonyl fluoride, and 5 mmol/L microcystin). The supernatant was heated to 1001C for 5 mins before electrophoresis. Electrophoresis was performed in 0.1% (w/v) SDS, 25 mmol/L Trishydroxymethyl aminomethane, and 192 mmol/L glycine at 12 mA constant current/8 cm Â 5 cm Â 0.75 mm gel for 100 mins. After electrophoresis, the gel was soaked in transfer buffer (25 mmol/L Tris, 192 mmol/L glycine, and 10% (v/v) methanol) containing 2 mmol/L EDTA to remove Mn 2 + for 30 mins, and then in transfer buffer without EDTA for 15 mins. Proteins were then transferred to polyvinylidene difluoride membrane (0.2 mm pore size; Bio-Rad, Hercules, CA, USA) in transfer buffer for 2 h at room temperature. The membranes were then washed in phosphate-buffered saline (PBS; 136.9 mmol/L NaCl, 2.7 mmol/L KCl, 8.1 mmol/L Na 2 HPO 4 , and 1.47 mmol/L KH 2 PO 4 ) for 5 mins, and treated with 0.5% (w/v) formaldehyde in PBS for 45 mins (Takeya et al, 2008) . After a brief wash in PBS containing 0.1% Tween-20 (T-PBS), the membrane was blocked with 5% (w/v) skimmed milk in T-PBS overnight at 41C. In the immunoblot detection, all forms of 20 kDa MLCs were detected using a rabbit polyclonal anti-MLC antibody (sc-15370; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (Sigma, St Louis, MO, USA). Primary and secondary antibodies were diluted at 500-fold and 1,000-fold, respectively, in immunoreaction enhancer solution (Can Get Signal; Toyobo, Osaka, Japan). The immune complex was detected using enhanced chemiluminescence technique (ECL plus kit; Amersham, Buckinghamshire, UK). The light emission was detected and analyzed with ChemiDoc XRS-J and the computer program Quantity One (Bio-Rad). The percentage of the phosphorylated forms in total MLCs (sum of unphosphorylated and phosphorylated forms) was calculated to indicate the extent of MLC phosphorylation. The extract from one ring preparation was sufficient to permit the quantification of MLC phosphorylation.
Immunoblot Analysis of the Expression of ET A Receptor, Proteinase-Activated Receptor 1 (PAR 1 ), and a 1 -Adrenoceptor
The isolated basilar arteries were homogenized in 50 mmol/L HEPES, pH 7.4, 150 mmol/L NaCl, 0.5% (v/v) Nonidet P-40, 1 mmol/L EDTA, 1 mmol/L DTT, 0.5 mmol/L Na 3 VO 4 , 10mg/mL leupeptin, 10 mg/mL aprotinin, and 10 mmol/L 4-aminidophenylmethane sulphonyl fluoride. A total of 5 mg of protein was separated by SDS-PAGE and was then transferred to the polyvinylidene difluoride membrane (Bio-Rad). The membranes were blocked with 5% (w/v) skimmed milk in T-PBS overnight at 41C. Next, the membrane was incubated for 1 h at room temperature with anti-ET A receptor antibody (sc-33535; Santa Cruz Biotechnology), anti-PAR 1 antibody (sc-5605; Santa Cruz Biotechnology), or anti-a 1 -adrenoceptor antibody (sc-28982; Santa Cruz Biotechnology) diluted 200-fold in Can Get Signal (Toyobo), followed by 1-h incubation with the secondary antibody conjugated with horseradish peroxidase (1,000-fold dilution). The immune complex was detected using an ECL plus kit. The detection and analysis of the chemiluminescence signals were as noted above. After chemiluminescence detection, the membranes were stained with naphthol blue black to visualize the band corresponding to actin. The optical density of the each receptor band was normalized to that of actin.
Drugs and Solution
The composition of normal PSS was 123 mmol/L NaCl, 4.7 mmol/L KCl, 1.25 mmol/L CaCl 2 , 1.2 mmol/L MgCl 2 , 1.2 mmol/L KH 2 PO 4 , 15.5 mmol/L NaHCO 3 , and 11.5 mmol/L D-glucose. The PSS was aerated with a mixture of 95% O 2 and 5% CO 2 , with the resulting pH being 7.4. High K + PSS was prepared by replacing NaCl with equimolar KCl. The composition of Ca 2 + -free CSS was 100 mmol/L potassium methanesulphonate, 2.2 mmol/L Na 2 ATP, 3.38 mmol/L MgCl 2 , 10 mmol/L EGTA, 10 mmol/ L creatine phosphate, and 20 mmol/L Tris-malate (pH 6.8). The CSS containing the indicated concentration of free Ca 2 + was prepared by adding an appropriate amount of CaCl 2 , while assuming the Ca 2 + -EGTA binding constant to be 10 6 (L/ mol) . Thrombin (bovine plasma; 1,178 NIH units/mg protein), Staphylococcus aureus a-toxin, GTPgS, phorbol 12,13-dibutyrate (PDBu), phenylephrine, and 4amidinophenylmethanesulfonyl fluoride were purchased from Sigma. Endothelin-1 was obtained from Peptide Institute (Osaka, Japan). TFLLR-NH 2 (PAR 1 activating peptide) was obtained from Bachem (Budendorf, Switzerland). Trypsin was purchased from Difco Laboratories (Detroit, MI, USA). Fura-2 acetoxymethyl ester was purchased from Dojindo Laboratories (Kumamoto, Japan). Rabbit polyclonal anti-phospho-MLC (Ser19; no. 3671) and phospho-MLC (Thr18/Ser19; no. 3674) antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). YM254890 was a kind gift from Astellas Pharma (Tokyo, Japan).
Data Analysis
The data are expressed as the mean ± s.e.m. of the indicated experimental number. One basilar arterial preparation obtained from one animal was used for each experiment, and therefore the number of experiments (n value) indicates the number of animals. Unpaired Student's t-test was used to determine statistical differences between the two groups. A value of P < 0.05 was considered to be statistically significant.
Results
Enhanced Contractile Response of the Rabbit Basilar Artery to Endothelin-1, Thrombin and Phenylephrine after Subarachnoid Hemorrhage (SAH)
Depolarization with 118 mmol/L K + induced a sustained increase in tension in the rabbit basilar artery in both the controls and SAH ( Figure 1A) . The absolute values of the tension induced by 118 mmol/ L K + in SAH did not significantly differ from that observed in the controls ( Figure 1B) . Therefore, the contractile response to 118 mmol/L K + was recorded as a reference response at the beginning of each measurement and thus assigned to be 100%. The level of tension obtained with different concentrations of K + did not significantly differ between the controls and SAH at any concentrations ( Figure 1C) .
The evaluation of the concentration-dependent responses to endothelin-1 revealed significant enhancement of contractile responses at 3, 10, and 30 nmol/L in SAH compared with those observed in the controls, whereas the contraction obtained with 100 nmol/L endothelin-1 in SAH was similar to that observed in the controls ( Figure 1D ). The contractile response to thrombin and phenylephrine was significantly enhanced after SAH at concentrations higher than 0.01 unit/mL and 3 mmol/L, respectively ( Figure 1D ). An immunoblot analysis of the expression of ET A receptor, PAR 1 , and a 1 -adrenoceptor showed the level of expression of all receptors examined to significantly increase in SAH ( Figure 1E ).
In the controls, 100 nmol/L endothelin-1 induced a contraction, which reached the peak (143.6% ± 13.8% of the 118 mmol/L K + -induced contraction, n = 5) at 12 mins, and thereafter gradually and significantly declined, reaching the level of 85.0% ± 16.3% (n = 5) at 45 mins (Figures 2A and 2B ). In SAH, endothelin-1 induced a contraction, which reached a similar peak level with a similar time course as that observed in the controls (Figures 2A  and 2B ). However, there was no significant decline in the level of tension even at 45 mins (Figures 2A and 2B) . Thrombin (1 unit/mL) induced a significant, but small, contraction, which reached a peak at 15 mins and thereafter declined to the significantly lower level at 45 mins in the controls (Figures 2A and 2B ). In SAH, thrombin induced not only a greater tension development at 15 mins than that observed in the controls, but also a sustained contraction without a significant decline at 45 mins (Figures 2A and 2B ). Phenylephrine (10 mmol/L) induced a transient contraction with a peak at 6 mins in the controls, whereas it induced not only an enhanced, but also a sustained contraction in SAH (Figures 2A and 2B) . The time course of the changes in [Ca 2 + ] i correlated with that observed with tension for all agonists (Figures 2A and 2B ). Endothelin-1 increased [Ca 2 + ] i to a similar peak level in both controls and SAH.
[Ca 2 + ] i thereafter slightly declined in the controls, whereas it remained elevated in SAH. Both thrombin and phenylephrine induced a small transient elevation of [Ca 2 + ] i in the controls, whereas they induced an enhanced and sustained elevation in SAH.
The Phosphorylation of myosin light chains (MLCs) During the Contraction Induced by Endothelin-1, Thrombin, and Phenylephrine in the Rabbit Basilar Artery Phos-tag SDS-PAGE followed by immunoblot detection with anti-MLC antibody yielded three bands with an apparent molecular size of 20, 23, and 29 kDa in the extract of the basilar arteries obtained before and after the stimulation with endothelin-1 ( Figure 3A) . The upper and middle bands were also detected by antiphospho-MLC (Thr18/Ser19) and phospho-MLC (Ser19) antibodies, respectively ( Figure 3A) . Conver-sely, the conventional SDS-PAGE without Phos-tag yielded only a single immunoreactive band with anti-MLC antibody (data not shown). These observations thus indicated the upper, middle, and lower bands to represent di-, mono-, and non-phosphorylated forms of MLC, respectively ( Figure 3A) . The control basilar arteries contained 39.5% ± 1.0% and 17.6% ± 1.5% of mono-and di-phosphorylated forms of MLC before the contractile stimulation (n = 15), whereas those of SAH contained 44.7%± 2.5% and 15.1% ± 1.6% (n = 15), respectively. There was no significant difference in the resting level of MLC phosphorylation (the sum of di-and monophosphorylation) between the controls and SAH. ] i and tension induced by 100 nmol/L endothelin-1, 1 unit/mL thrombin, and 10 mmol/L phenylephrine in the fura-2loaded basilar artery of the controls and SAH. In (B), the time course of [Ca 2 + ] i was evaluated at three time points: just before the stimulation (0 min), at the peak of the tension development observed with each agonist (12, 15, or 6 min), and 45 min after the stimulation. The data represent the mean ± s.e.m. (n = 5 to 7). The levels of [Ca 2 + ] i and tension obtained at rest and 5 mins after initiating a contraction by 118 mmol/L K + -physiological salt solution (PSS) were assigned values of 0% and 100%, respectively. *P < 0.05 versus resting level (0 min); # P < 0.05; n.s., not significantly different.
Endothelin-1 (100 nmol/L) significantly increased the MLC phosphorylation to a similar level in the controls and SAH, at the peak of the tension development (12 mins; Figure 3B ). The level of MLC phosphorylation thereafter declined in the controls, whereas it remained sustained in SAH ( Figure 3B ). Thrombin (1 unit/mL) and phenylephrine (10 mmol/L) induced no significant increase in the MLC phosphorylation at any time in the controls, whereas they induced a significant and sustained increase in the MLC phosphorylation in SAH ( Figure  3B ). As a result, the changes in the agonist-induced MLC phosphorylation correlated with the changes in [Ca 2 + ] i and tension in both the controls and SAH.
As a result, the conversion of a transient response to a sustained response in SAH was common to all agonists examined. Notably, this conversion was observed with all parameters: [Ca 2 + ] i , MLC phosphorylation, and tension.
Changes in the Intracellular Mechanisms of Smooth Muscle Contraction in the Rabbit Basilar Artery After Subarachnoid Hemorrhage (SAH)
To elucidate the mechanism for enhanced and sustained contractile responses in SAH, any changes in the intracellular mechanisms involved in smooth muscle contraction were evaluated. For this purpose, the contractile response to the direct activation of protein kinase C by PDBu was first examined in intact preparations. In both controls and SAH, 300 nmol/L PDBu induced a precipitous initial contraction, followed by a steady sustained contraction ( Figure 4A ). There was no significant difference in the level of tension development between the controls and SAH at the initial peak and 30 mins after the initiation of the contraction ( Figure 4B ). The concentration-dependent effects of PDBu also did not significantly differ between the controls and SAH ( Figure 4C ).
Next, any alteration in the Ca 2 + -dependent contractile mechanism or the myofilament Ca 2 + sensitivity after SAH was analyzed by using a-toxin-permeabilized preparations. In this experiment, GTPgS, a nonhydrolyzable GTP analog, which is known to directly activate G proteins by skipping the receptormediated activation (Cockcroft and Gomperts, 1985; Gilman, 1984) , was used to increase the Ca 2 + sensitivity. A stepwise increase in Ca 2 + concentrations induced a similar stepwise development of tension in the controls and SAH ( Figure 4D ). In the presence of 10 mmol/L GTPgS, the pCa 2 + tension curves shifted to the left to a similar extent in both the controls and SAH ( Figure 4D ). During the 180 nmol/L Ca 2 + -induced sustained contraction, 10 mmol/L GTPgS induced a further development of tension in both the controls and SAH ( Figure 4E ). The level of peak contraction observed in SAH was similar to that observed in the controls ( Figure 4E ). In the controls, the tension thereafter gradually decreased and the level observed at 25 mins was significantly lower than that observed at the peak ( Figure 4E ). In contrast, there was no significant decline in the level of tension in SAH ( Figure 4E) . As a result, the transient contractile response to GTPgS in the controls was converted to the sustained response in SAH.
Impairment of the Tachyphylaxis of Agonist-Induced Contractile Responses in the Rabbit Basilar Artery After Subarachnoid Hemorrhage (SAH)
To further elucidate the mechanism of the enhanced and sustained contraction after SAH, the tachyphylaxis of the agonist-induced contractile responses was analyzed by examining the reduction of the second response during the consecutive stimulation of the arteries with the same agonist. For this purpose, 100 mmol/L PAR 1 -AP and 50 mmol/L phenylephrine was used to induce a significant contraction in the controls. PAR 1 -AP induced little contraction at 10 mmol/L, whereas it induced an enhanced contraction in SAH (data not shown). However, the contraction induced by 100 mmol/L PAR 1 -AP in the controls (331±25 mg, n = 5) was similar to that observed in SAH (304 ± 37 mg, n = 5; Figure 5A ). Conversely, the contraction induced by 50 mmol/L phenylephrine in the controls (108.8±11.5 mg, n = 5) was significantly enhanced in SAH (183.4 ± 21.8 mg, n = 5; Figure 5B ). After recording the first response to 100 mmol/L PAR 1 -AP or 50 mmol/L phenylephrine for 5 mins, the rings were equilibrated in PSS without stimulation for 10 mins, and then they were challenged to the second stimulation with same agonists (Figure 5 ). In the controls, the second response to PAR 1 -AP and phenylephrine was significantly reduced to 29.9% ± 5.1% (n = 5) and 51.7%±7.2% (n = 5) of the first response, respectively ( Figure 5 ). This reduction of the second response was significantly and substantially attenuated in SAH ( Figure 5 ).
The Effect of Trypsin on the Thrombin-Induced Sustained Contraction in the Rabbit Basilar Artery After Subarachnoid Hemorrhage (SAH)
Thrombin activates its receptor by proteolytically cleaving the extracellular domain of PAR 1 at the residues 41 to 42, thereby unveiling a new N-terminus that then exerts an effect as a tethered ligand to activate the receptor. Therefore, the thrombin activation of PAR 1 is an irreversible process (Macfarlane et al, 2001) . The mechanism of feedback regulation helps to terminate its signaling activity (Hollenberg and Compton, 2002; Macfarlane et al, 2001) . Otherwise, PAR 1 signaling would persist. In SAH, the thrombin-induced contraction persisted even after removing thrombin and adding 10 mmol/L 4-amidinophenylmethanesulfonyl fluoride, a protease inhibitor ( Figure 6A) . The contribution of the persisted signaling activity of PAR 1 to this irreversible contraction was first analyzed by examining the effect of trypsin on the sustained phase of the contraction. Trypsin has been shown to cleave the extracellular domain of PAR 1 at the residues 71 to 72 and/or 82 to 83 (in humans), thereby removing the tethered ligand region (Nakayama et al, 2004) . The addition of 10 mmol/L trypsin during the thrombininduced sustained contraction completely inhibited the contraction to the resting level ( Figures 6B) . However, trypsin had no effect on the sustained contraction induced by 118 mmol/L K + or endothelin-1 ( Figures 6C and 6D) .
The Effect of YM254890 on the Agonist-Induced Contraction in the Rabbit Basilar Artery After Subarachnoid Hemorrhage (SAH)
Next, the persistent receptor activity during the sustained contraction was analyzed by examining the effect of YM254890, a selective Ga q inhibitor, on the sustained phase of the contraction. YM254890 inhibited the thrombin-induced sustained contraction, with complete inhibition at 100 nmol/L ( Figures  7A and 7B ). YM254890 also completely inhibited the contraction induced by 100 nmol/L endothelin-1 and 30 mmol/L phenylephrine at 100 nmol/L ( Figures 7A  and 7B ). Furthermore, the [Ca 2 + ] i elevations induced by these agonists were completely inhibited by 100 nmol/L YM254890 (data not shown). The IC 50 values of YM254890 for the inhibition of the contraction induced by thrombin, endothelin-1, and Figure 4 Contractile responses of the intact artery to phorbol 12,13-dibutyrate (PDBu) and the a-toxin-permeabilized artery to GTPgS in the controls and subarachnoid hemorrhage (SAH). (A-C) The contractile responses to PDBu in the intact basilar artery of the controls and SAH. (A) Representative recordings showing the tension development induced by 300 nmol/L PDBu in the fura-2unloaded intact basilar artery of the controls and SAH. (B) The levels of tension obtained at the peak and 30 mins after the stimulation and (C) the concentration-response curves for the PDBu-induced tension development in the controls and SAH. The levels of tension obtained at the rest and 5 mins after initiating a contraction by 118 mmol/L K + -physiological salt solution (PSS) were assigned values of 0% and 100%, respectively, in the intact artery. (D, E) The contractile responses to GTPgS in the a-toxinpermeabilized artery of the controls and SAH. (D) The pCa 2 + -tension curves of the contraction induced by stepwise increment of Ca 2 + concentrations in the absence and presence of 10 mmol/L GTPgS, and in the controls and SAH. (E) Representative recordings and summary of the contractions induced by 10 mmol/L GTPgS during the 180 nmol/L Ca 2 + -induced contractions in the controls and SAH. The level of tension was evaluated at the peak, and at 15 mins and 25 mins after initiating the contraction by GTPgS, as indicated by arrowheads in the traces. The response to 10 mmol/L Ca 2 + was recorded as a reference response at the end of each experiment, and this level of tension was assigned a value of 100%, whereas that obtained in Ca 2 + -free cytosolic substitution solution (CSS) was assigned values of 0% in the permeabilized artery. The data represent the mean ± s.e.m. (n = 5). n.s., not significantly different; *P < 0.05; # P < 0.05 versus controls. phenylephrine were 69.8, 69.7, and 84.9 nmol/L, respectively. Conversely, YM254890, even at 1 mmol/L, had no significant effect on the level of [Ca 2 + ] i (data not shown) and tension ( Figure 7A ) during the contraction induced by 300 nmol/L PDBu or 118 mmol/L K + .
Discussion
The most noticeable observation of this study is that the contractile response of the isolated basilar artery to three G protein-coupled receptor agonists was not only enhanced but also sustained after SAH. In the controls, the contractions induced by endothelin-1, thrombin, and phenylephrine declined more or less after reaching the peak of contraction despite the continuous presence of the receptor stimulation. In SAH, these contractions sustained with no significant decline. In addition, the experiments of the consecutive stimulations showed that the responsiveness to the second stimulation was substantially attenuated in the control artery, whereas it was maintained in SAH. These observations therefore suggest that some negative feedback regulation of the contractile response was impaired in SAH, thus converting the transient response to the sustained response and also maintaining the responsiveness to the second stimulation. In this respect, it is noteworthy that the conversion of the transient response to the sustained response was observed with not only tension but also with [Ca 2 + ] i and MLC phosphoryla- Figure 5 Contractile response of basilar artery to the consecutive stimulation with PAR 1 -AP (proteinase-activated receptor 1activating peptide) and phenylephrine in the controls and subarachnoid hemorrhage (SAH). (A, B) Representative recordings and summary showing the contractile responses to the consecutive stimulation with 100 mmol/L PAR 1 -AP (A) and 50 mmol/L phenylephrine (B) in the fura-2-unloaded ring preparations. The rings were consecutively stimulated with PAR 1 -AP or phenylephrine for 5 mins with a 10-min interval of incubation without contractile stimulation. The response to the second stimulation was evaluated by assigning the response to the first stimulation to be 100%. The data represent the mean±s.e.m. (n = 5). n.s., not significantly different; *P < 0.05.
tion. This observation therefore suggests that the mechanism that was impaired in SAH reside at the upstream of the Ca 2 + signal, and presumably at a receptor level. In addition, the GTPgS-induced contraction observed at the fixed Ca 2 + concentration in the permeabilized rings also declined in the control artery, whereas it remained sustained in SAH. This observation thus suggests another feedback regulation to reside at a level of regulation of the myofilament Ca 2 + sensitivity, which was also impaired in SAH. As a result, this study suggests that the impaired feedback regulation of the receptor activity and the myofilament Ca 2 + sensitivity have a critical role in the increased vascular reactiveness in SAH.
The mechanism for cerebral vasospasm can be attributable to either increased production of spasmogens or increased vascular reactiveness (Kai et al, 2008) . The increase in the vascular reactiveness may result from either endothelial dysfunction Sasaki et al, 1986) or an increase in the smooth muscle contractility .
This study proposes the impairment of the feedback regulation of the contractile response as a novel mechanism contributing to the increased vascular reactiveness in SAH. The receptor upregulation contributes to the increased contractile responses in SAH (Hansen-Schwartz et al, 2003; Itoh et al, 1994; Kai et al, 2007; Maeda et al, 2007; Vatter et al, 2007) . However, this could explain the increased responses to certain spasmogens. In contrast, the impaired feedback regulation of the receptor activity seems to affect a broad range of G protein-coupled receptors, thus contributing to the reported increase in the contractile response to various spasmogens (Hansen-Schwartz et al, 2003; Itoh et al, 1994; Kai et al, 2007; Kai et al, 2008; Maeda et al, 2009; Maeda et al, 2007; Vatter et al, 2007) .
The impairment of the feedback regulation of the receptor activity in SAH is convincingly suggested for PAR 1 . The thrombin activation of PAR 1 is an irreversible process (Macfarlane et al, 2001) . The subsequent receptor phosphorylation, b-arrestin binding, endocytotic internalization, and lysosomal degradation thus help to terminate the signaling activity of PAR 1 (Hollenberg and Compton, 2002; Trejo, 2003) . Otherwise, PAR 1 signaling would persist even after the termination of thrombin stimulation, as previously reported in Sf9 cells or metastatic breast cancer cells (Booden et al, 2004; Chen et al, 1996; Trejo, 2003) . The observation that the thrombin-induced contraction irreversibly persisted after terminating the thrombin stimulation therefore suggests the impairment of the receptor inactivation. Furthermore, the observations with trypsin and YM254890 support the persistent signaling activity of PAR 1 during the thrombin-induced contraction. The removal of the tethered ligand region of PAR 1 by proteinases converts PAR 1 to the inactive conformation, thereby terminating the irreversibly persisted signals (Holinstat et al, 2009 ). Trypsin is one such proteinase and it removes the tethered ligand region of PAR 1 (Nakayama et al, 2004; Nakayama et al, 2003) . The inhibition of the thrombin-induced sustained contraction by trypsin thus suggests the requirement of the active conformation of PAR 1 for the thrombin-induced sustained contraction. Because the contractile responses to endothelin-1 and phenylephrine were also converted from the transient response in the controls to the sustained response in SAH, and YM254890 also inhibited the sustained phase of these contractions, the feedback regulation of ET A receptor and a 1adrenoceptor is also suggested to be impaired after SAH.
The general impairment of the receptor inactivation may be consistent with previous reports showing the enhanced contractile response to various receptor ligands (Hansen-Schwartz et al, 2003; Itoh et al, 1994; Kai et al, 2007; Kai et al, 2008; Maeda et al, 2009; Maeda et al, 2007; Vatter et al, 2007) . However, the impaired receptor inactivation exerts a significant effect especially on the activity of ET A receptor and PAR 1 . The affinity of ET A receptor for endothelin-1 is extremely high, and therefore their binding is practically irreversible under physiological conditions (Endo et al, 2005; Freedman et al, 1997) . Conversely, PAR 1 activation is an irreversible process. The impaired receptor inactivation therefore has a greater effect on the signaling activity of PAR 1 than other receptors. The massive hemorrhage around cerebral arteries is the fundamental pathology of SAH, which causes the extensive production of thrombin. The increased reactiveness of the basilar Figure 7 The effects of YM254890 on the contractions induced by thrombin, endothelin-1, phenylephrine, phorbol 12,13dibutyrate (PDBu), and 118 mmol/L K + depolarization in the rabbit basilar artery with subarachnoid hemorrhage (SAH). (A) Representative recordings showing the effect of YM254890 on the contraction induced by 100 nmol/L endothelin-1, 1 unit/mL thrombin, 30 mmol/L phenylephrine, 300 nmol/L PDBu, and 118 mmol/L K + in the fura-2-unloaded ring preparations of SAH. (B) Concentration-dependent effects of YM254890 on the contraction induced by 1 unit/mL thrombin, 100 nmol/L endothelin-1, and 30 mmol/L phenylephrine in SAH. The relaxant effect of YM254890 was evaluated by assigning the level of tension obtained just before the application of YM254890 and that obtained in the normal physiological salt solution (PSS) before initiating the precontraction to be 100% and 0%, respectively. The data represent the mean ± s.e.m. (n = 5). artery to thrombin is characteristic of SAH. Thrombin and its receptor PAR 1 are therefore suggested to have an important role in the development of cerebral vasospasm.
The mechanism for the impairment of the receptor inactivation in SAH still remains to be elucidated, with regard to how SAH causes such impairment and which step of the feedback regulation is impaired. The phosphorylation of receptor by G proteincoupled receptor kinases and the binding of barrestin to receptor contribute to the rapid termination of receptor signaling, while the endocytotic internalization and the lysosomal degradation also contribute to the subsequent termination (Drake et al, 2006; Moore et al, 2007) . The relative contribution of each step and precise molecular mechanism varies depending on the type of receptor (Abe et al, 2000; Chalothorn et al, 2002; Freedman et al, 1997) . Therefore, the step common to ET A receptor, PAR 1 , and a 1 -adrenoceptor is considered to be impaired in SAH, and the molecule(s) positively or negatively involved in such a step may be up-or downregulated in the cerebral artery after SAH. Those molecules still remain to be identified.
The present study also suggests the impairment of the feedback regulation at the step regulating the myofilament Ca 2 + sensitivity in SAH. However, the importance of this impairment may vary with the contractile stimulation, depending on the degree of contribution of the myofilament Ca 2 + sensitization to the contractile response. The evaluation of the [Ca 2 + ] itension relationship based on the observations in Figure 2 suggests that Ca 2 + sensitization makes a relatively greater contribution to the endothelin-1induced contractions than other contractions. Rho kinase and protein kinase C are two major signaling molecules known to contribute to the myofilament Ca 2 + sensitization (Hirano, 2007) . The activation of protein kinase C by PDBu induced a sustained contraction in cerebral artery. However, this contractile response remained unchanged after SAH, thus ruling out the major contribution of protein kinase C to the feedback regulation of the myofilament Ca 2 + sensitivity. Conversely, the activity of Rho kinase is upregulated in SAH (Miyagi et al, 2000; Sato et al, 2000) . The increased Rho kinase activity may therefore contribute to the persistent increase in the myofilament Ca 2 + sensitivity in SAH, especially in the endothelin-induced contraction.
In SAH, the maximal contractile responses to thrombin and phenylephrine were greatly enhanced, whereas the concentration-response curve of endothlin-1 was shifted to the left. This study showed the upregulation of receptors for all these agonists in SAH. The upregulation of ET A receptor and PAR 1 is consistent with the observations of the previous reports (Ide et al, 1989; Itoh et al, 1994; Maeda et al, 2007; Vatter et al, 2007) , whereas no study has previously reported the upregulation of a 1 -adrenoceptor in SAH. The upregulation of PAR 1 and a 1adrenoceptor may be consistent with the enhance-ment of the maximal response. However, the upregulation of ET A receptor was not associated with the enhancement of the maximal response to endothelin-1. The reason for this, however, remains unknown. It may be related to a large population of the spare receptor for ET A receptor or a relatively lower degree of the upregulation in comparison to that observed with PAR 1 and a 1 -adrenoceptor ( Figure 1E) .
In conclusion, this study provides the first evidence that the feedback regulation of the smooth muscle contraction is impaired in SAH. The impairment of this feedback regulation is suggested to contribute to the persistent receptor signaling and the sustained increase in the myofilament Ca 2 + sensitivity. The impaired feedback regulation is thus suggested to contribute to the increased vascular reactiveness, and therefore the pathogenesis of cerebral vasospasm.
